Countries in Africa are having to seek alternative funding amid a block to US funding for mpox response efforts.

To avoid overlaps, the industry is calling for aligning MDR/IVDR with the EU's digital frameworks, pharmaceutical regulations, and clinical trial regulations.

We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority ...

Market was valued at USD 336.07 million in 2024 and is expected to reach USD 441.23 million by 2033, growing at a CAGR of 4.60% during the forecast period. The market is experiencing substantial ...

is proud to announce that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the European Union’s new In Vitro Diagnostic Medical Devices ...

The Dutch company’s prospective real-world evidence study of 109 newly diagnosed MM patients and 149 with relapsed/refractory MM (r/r MM) combined its MMprofiler with SKY92 gene expression profiling ...

sero reactive blood bags from blood centres as a raw material for preparing in vitro diagnostic (IVD) reagents. Also Read | Medical devices maker Poly Medicure to focus on exports amid ...

The diagnostic devices, FemCerv and FemVue ... offering a lower-risk alternative before considering in vitro fertilisation (IVF). FemCerv, the first Food and Drug Administration (FDA)-cleared ...

The global in vitro diagnostics (IVD) market encompasses a wide range of medical devices, reagents, and testing methodologies used for diagnosing diseases and monitoring patient health outside of the ...